The effect and mechanism of preoperative oral administration of galangal capsules on liver ischemia-reperfusion injury in patients undergoing radical liver cancer surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400089283

Enrollment

Unknown

Registered

2024-09-05

Start date

2024-09-09

Completion date

Unknown

Last updated

2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative liver ischemia-reperfusion injury

Interventions

placebo group:Oral empty edible capsule shell

Gaoliang Ginger Vegetarian Capsules group:Oral Gaoliang Ginger Vegetarian Capsules

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1) Age range: 18-64 years old; 2) ASA classification levels ?/?; 3) Preoperative liver function was normal; 4) No previous history of liver or gallbladder surgery; 5) Liver cancer without metastasis; 6) Dysfunction of important organs such as heart, lungs, brain, and kidneys.

Exclusion criteria

Exclusion criteria: 1) Preoperative liver dysfunction; 2) Combined dysfunction of important organs such as the heart, lungs, brain, and kidneys; 3) Patients with a history of mental illness; 4) People who are allergic to sorghum.

Design outcomes

Primary

Measure	Time frame
Alanine transaminase (ALT);Aspartate transaminase (AST);Interleukin-6;Phosphatidylinositol 3-kinase;Arbejdsgiverforeningen for Kollektiv;Mammalian Target of Rapamycin;	—

Countries

China

Contacts

Public ContactLi Jing

Yilong County People's Hospital

903381234@qq.com+86 181 2191 7691

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026